nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are We Coalescing on the Best Approach for Hybrid Ablation of Atrial Fibrillation? ∗
|
Gehi, Anil K. |
|
|
6 |
13 |
p. 1616-1618 |
artikel |
2 |
Body Mass Index, Sex, and Incident Atrial Fibrillation in Diabetes
|
Singleton, Matthew J. |
|
|
6 |
13 |
p. 1713-1720 |
artikel |
3 |
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure
|
Dixit, Sanjay |
|
|
6 |
13 |
p. 1732-1734 |
artikel |
4 |
Catheter Ablation Versus Medication in Atrial Fibrillation and Systolic Dysfunction
|
Sugumar, Hariharan |
|
|
6 |
13 |
p. 1721-1731 |
artikel |
5 |
Clinical Outcomes of Warfarin Initiation in Advanced Chronic Kidney Disease Patients With Incident Atrial Fibrillation
|
Agarwal, Manyoo A. |
|
|
6 |
13 |
p. 1658-1668 |
artikel |
6 |
Direct Oral Anticoagulant Versus Warfarin for Watchman Left Atrial Appendage Occlusion—Systematic Review
|
Garg, Jalaj |
|
|
6 |
13 |
p. 1735-1737 |
artikel |
7 |
Dobutamine Instead of Isoproterenol for Atrial Triggers ∗
|
Badin, Auroa |
|
|
6 |
13 |
p. 1711-1712 |
artikel |
8 |
Dual-Location, Regional Signal Analysis During Ablation of Persistent Atrial Fibrillation
|
Kalifa, Jérôme |
|
|
6 |
13 |
p. 1631-1632 |
artikel |
9 |
Electrical Isolation of the Marshall Bundle by Radiofrequency Catheter Ablation
|
Kashimura, Shin |
|
|
6 |
13 |
p. 1647-1657 |
artikel |
10 |
High-Dose Dobutamine for Inducibility of Atrial Arrhythmias During Atrial Fibrillation Ablation
|
Gianni, Carola |
|
|
6 |
13 |
p. 1701-1710 |
artikel |
11 |
Impact of Left Atrial Appendage Closure on LAA Thrombus Formation and Thromboembolism After LAA Isolation
|
Fink, Thomas |
|
|
6 |
13 |
p. 1687-1697 |
artikel |
12 |
Intracardiac Echocardiography
|
Meyer, Christian |
|
|
6 |
13 |
p. 1643-1646 |
artikel |
13 |
Left Atrial Appendage Isolation for Ablation of Atrial Fibrillation
|
Steinberg, Jonathan S. |
|
|
6 |
13 |
p. 1698-1700 |
artikel |
14 |
Right Atrial Complexity Evolves With Stepwise Left-Sided Persistent Atrial Fibrillation Substrate Ablation and Predicts Outcomes
|
Johner, Nicolas |
|
|
6 |
13 |
p. 1619-1630 |
artikel |
15 |
Should CHA2DS2-VASc Be Spelled With “V” or “V2”? ∗
|
Okabe, Toshimasa |
|
|
6 |
13 |
p. 1683-1686 |
artikel |
16 |
Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation
|
Ellis, Christopher R. |
|
|
6 |
13 |
p. 1603-1615 |
artikel |
17 |
The Watchman FLX Device
|
Korsholm, Kasper |
|
|
6 |
13 |
p. 1633-1642 |
artikel |
18 |
Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease
|
Melgaard, Line |
|
|
6 |
13 |
p. 1672-1682 |
artikel |
19 |
Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease
|
Pun, Patrick H. |
|
|
6 |
13 |
p. 1669-1671 |
artikel |